SCHEMBL19494396

SCHEMBL19494396

CC(C)(C)C(O)C(=O)Nc1sc(Sc2ccc(F)cc2)cc1C(N)=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CFTR P13569 6/20 0.43
▸ IKBKB O14920 6/20 0.43
▸ MEN1 O00255 4/20 0.43
▸ KMT2A Q03164 4/20 0.43
▸ JAK2 O60674 2/20 0.43
▸ EIF2AK2 P19525 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ HDAC6 Q9UBN7 1/20 0.43
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ HTT P42858 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ USP2 O75604 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ GFER P55789 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19494413 0.89 IKBKB (0.46) CFTRIKBKBMEN1KMT2AJAK2
SCHEMBL19494938 0.83 MEN1 (0.41) CFTRIKBKBMEN1KMT2AJAK2
SCHEMBL19494898 0.80 JAK2 (0.45) CFTRIKBKBMEN1KMT2AJAK2
SCHEMBL16263917 0.77 CFTR (0.73) CFTRIKBKBMEN1KMT2AJAK2
SCHEMBL19494397 0.77 CFTR (0.44) CFTRIKBKBMEN1KMT2AJAK2
SCHEMBL19494442 0.75 MEN1 (0.42) CFTRIKBKBMEN1KMT2AJAK2
SCHEMBL16387372 0.75 IKBKB (0.44) IKBKBMEN1KMT2AJAK2CYP1A2
SCHEMBL19494512 0.74 IKBKB (0.41) CFTRIKBKBMEN1KMT2AJAK2
SCHEMBL19494934 0.74 KMT2A (0.41) CFTRIKBKBMEN1KMT2AJAK2
SCHEMBL19494660 0.74 TYK2 (0.46) CFTRIKBKBMEN1KMT2AJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2994463-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS GALAPAGOS NV (BE) 2017-10-25 — — EP disclosed
Send feedback